News

Continuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
Oura has announced a new glucose integration with Dexcom's Stelo and the permanent launch of its AI-powered food tracker, ...
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...
Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...
The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...
Is there such a thing as pre-prediabetes? My doctor says it’s happening to me, and he wants me to use one of those blood ...
In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...
(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.
Trends indicate increasing adoption among adults aged 20+, with significant expansion in the male CGM market. Key players include Dexcom, Inc., Abbott Laboratories, and Medtronic. The report offers ...